Melanoma antigen recognized by T-cells 1 Completed Phase 0 Trials for Stage IIB Skin Melanoma / Stage IV Melanoma / Stage IIA Cutaneous Melanoma / Stage IIC Skin Melanoma / Stage IIIB Skin Melanoma / Stage IIIA Skin Melanoma / Stage IIIC Skin Melanoma Treatment

Indications	Status	Purpose	Phase
DBCOND0054560 (Stage IIB Skin Melanoma) DBCOND0028660 (Stage IV Melanoma) DBCOND0155733 (Stage IIA Cutaneous Melanoma) DBCOND0054561 (Stage IIC Skin Melanoma) DBCOND0029534 (Stage IIIB Skin Melanoma) DBCOND0029533 (Stage IIIA Skin Melanoma) DBCOND0029535 (Stage IIIC Skin Melanoma)	Completed	Treatment	0

clinicaltrials.gov Identifier	Title	Drugs
NCT02320305	MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery	G100 (DB17244) Melanoma antigen recognized by T-cells 1 (DB15081)